Stay updated with breaking news from Alpine Immune Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw unusually-strong trading volume on Monday . Approximately 477,690 shares traded hands during trading, an increase of 256% from the previous session’s volume of 134,176 shares.The stock last traded at $12.60 and had previously closed at $12.20. Alpine Immune Sciences Stock Performance The firm […]
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) shares saw unusually-strong trading volume on Monday . Approximately 477,690 shares changed hands during trading, an increase of 256% from the previous session’s volume of 134,176 shares.The stock last traded at $12.60 and had previously closed at $12.20. Alpine Immune Sciences Price Performance The company has […]
Cyclo Therapeutics (NASDAQ:CYTH – Get Free Report) and Adaptimmune Therapeutics (NASDAQ:ADAP – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership. Analyst Ratings This is a summary of […]
Key Insights The considerable ownership by private equity firms in Alpine Immune Sciences indicates that they...
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) was the recipient of a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 1,530,000 shares, a growth of 26.4% from the June 15th total of 1,210,000 shares. Based on an average daily volume of 172,400 […]